Compugen hosts virtual KOL event on COM701 in ovarian cancer

By Public Technologies
  • Compugen will host a virtual KOL event on October 5, 2026 at 8:00 a.m. ET focused on COM701 in ovarian cancer.
  • Harvard Medical School’s Oladapo Yeku will join management to discuss the evolving ovarian cancer treatment landscape.
  • The session will also include an update on expanded capabilities of the Unigen AI/ML target discovery platform.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compugen Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609220700PR_NEWS_USPR_____IO53662) on September 22, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk